Sanborn Joseph sold $164K of EVER

Sanborn Joseph (CFO and Chief Admin Officer) sold 6,667 shares of EverQuote, Inc. (EVER) at $24.63 ($0.16M total) on 2026-07-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Sanborn Joseph
Published Jul 10, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 10, 2026, 8:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EVER
Neutral
high confidence
Mentioned
$EVER
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EVERNeutralLow
01

Why it matters

This is a disclosed open-market sale by the CFO under a pre-arranged 10b5-1 plan; it is primarily sentiment-level information rather than a new business catalyst.

02

Market read

Traders may note the insider sale for positioning and sentiment, but there is no new guidance, deal, or operational update in the text.

03

What to watch

The article does not disclose whether other insiders sold/bought around the same time, nor does it provide context on total insider ownership changes beyond the post-transaction share count.

Relevance 3/10Novelty 2/10Timing: Filed on 2026-07-10 after the 2026-07-08 sale.

Background

The article is an SEC Form 4 insider transaction disclosure for EverQuote, Inc.

Company-level read

Ticker impact

$EVERNeutralHigh confidence
Context

EverQuote CFO Sanborn Joseph sold 6,667 shares at $24.63 on a 10b5-1 plan, totaling $164,208.21.

Expected impact

Low likelihood of sustained price impact; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with an explicitly pre-arranged 10b5-1 plan, and the article contains no new operational, financial, or regulatory developments.

Market effects

Minimal read-across to the online lead-gen/insurtech sector because this is a single-company routine insider sale.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still reflect personal liquidity needs rather than bearish fundamentals, so the market may overreact.

Key entities

  • EverQuote, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Sanborn Joseph

    CFO and Chief Admin Officer who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EVERHigh

EverQuote (EVER) Stock Price Jumps As Q3 Earnings Back Growth

EverQuote (EVER) reported Q3 adjusted EBITDA margin of 16.3% and VMM of 28.7%, with Q4 guidance indicating a sequential VMM decline. The company is investing in agentic and LLM channels, which may compress margins in the near term. The article also highlights three other companies potentially undervalued by 30-35% according to the author's estimates.

$EVERMed

EverQuote: Q3 Earnings Snapshot

EverQuote reported Q3 net income of $18.2M, or 49 cents per share, with adjusted EPS of 72 cents. Revenue was $218.1M, exceeding analysts' estimates. The company expects Q4 revenue between $213M and $223M, according to Zacks Investment Research.